Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-22-040265
Filing Date
2022-03-30
Accepted
2022-03-30 17:28:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2210914d1_424b5.htm 424B5 451578
2 GRAPHIC tm2210914d1_424b5img001.jpg GRAPHIC 20353
3 GRAPHIC tm2210914d1_424b5img002.jpg GRAPHIC 20341
  Complete submission text file 0001104659-22-040265.txt   509073
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-231923 | Film No.: 22787962
SIC: 2834 Pharmaceutical Preparations